BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
BLCM
Delisted
BLCM was delisted on the 1st of June, 2023.
30 hedge funds and large institutions have $2.22M invested in Bellicum Pharmaceuticals, Inc. in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
Holders
30
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$105K | |
| 2 | +$24.3K | |
| 3 | +$16K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$13K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.82K |
Top Sellers
| 1 | -$1K | |
| 2 | -$903 | |
| 3 | -$343 | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$308 |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
-$55 |